Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05672719

Hemodynamic Testing Strategies to Assess Pulmonary Hypertension in Heart Failure

Conditions: Heart Failure

Sex: All
Ages: 18 Years – 75 Years
Enrollment: 74
Sponsor: Mount Sinai Hospital, Canada

Location: Canada

Summary

The goal of this observational study is to learn about heart function and high lung blood pressure in patients with heart failure. The main question[s] it aims to answer are whether we can improve the ability to predict patients who will have complications after they receive treatment including heart transplant and left ventricular assist devices.

Eligibility Criteria

Inclusion Criteria:Adults age 18 years or olderHeart failure with reduced ejection fraction (<40%)referred for RHC at our centre for evaluation of candidacy for advanced HF therapies.Exclusion Criteria:Severe valvular or complex congenital heart disease Short-term mechanical circulatory support for progressive cardiogenic shock (e.g. extracorporeal membrane oxygenation) Acute coronary syndrome or revascularization occurred within 7 days prior to the RHC.Pregnant or breast-feeding Known hypersensitivity to sodium nitroprusside Advanced liver dysfunction Reduced capacity or inability to provide informed consent

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05672719). StuddyBuddy aggregates publicly available trial information.